Projects

To analyze gene copy number variations on derivative chromosome 9 and its implications in clinical response to Imatinib in Chronic Myeloid Leukemia

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2017 - 2020

Project Lead

Dr Cecil Ross

Authors

Dr Cecil R., Dr Sweta S,

Project Status

completed

Project Type

Co-PI